Teligent Pharma, Inc. 2022-03-30 Health serious FDA
Health · FDA · Recall #FDA-D-0686-2022
Gentamicin Sulfate Cream USP, 0.1%, packaged in a) 15 g tubes, NDC 52565-085-15, b) 30 g… Recall
Issued March 30, 2022 · Teligent Pharma, Inc.
In March 2022, Teligent Pharma, Inc. recalled the Gentamicin Sulfate Cream USP, 0.1%, packaged in a) 15 g tubes, NDC 52565-085-15, b) 30 g…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
What you should do
- 1 Stop using Gentamicin Sulfate Cream USP, 0.1%, packaged in a) 15 g tubes, NDC 52565-085-15, b) 30 g… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Teligent Pharma, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Teligent Pharma, Inc.
- Category
- Health
- Recall date
- March 30, 2022
- Units affected
- Not reported
- Sold at
- Nationwide in the USA and Puerto Rico
- Recall number
- FDA-D-0686-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Teligent Pharma, Inc. has 17 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.